Description
BSE announces listing of 20,75,073 new equity shares of Vivo Bio tech Ltd issued through warrant conversion, effective August 18, 2025.
Summary
BSE has announced the listing of 20,75,073 new equity shares of Vivo Bio tech Ltd (Scrip Code: 511509) effective Monday, August 18, 2025. These shares were issued at Rs. 45 per share (Rs. 10 face value + Rs. 35 premium) to non-promoters through preferential allotment pursuant to warrant conversion.
Key Points
- Total new shares: 20,75,073 equity shares of Rs. 10 each
- Issue price: Rs. 45 per share (including Rs. 35 premium)
- Trading commencement: August 18, 2025
- ISIN: INE380K01017
- Distribution numbers: 17924817 to 19999889
- Shares rank pari-passu with existing equity shares
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Trading members must note the new securities for trading operations
- Lock-in restrictions apply to all allotted shares until February 28, 2026
- Proper identification using assigned distribution numbers required
Important Dates
- Allotment dates:
- May 28, 2025: 4,53,333 shares
- June 18, 2025: 7,40,740 shares
- June 25, 2025: 7,75,000 shares
- July 3, 2025: 1,06,000 shares
- Trading start date: August 18, 2025
- Lock-in expiry: February 28, 2026 (for all shares)
Impact Assessment
Minimal market impact as this is a standard equity listing process. The lock-in period until February 28, 2026 ensures shares cannot be traded immediately, providing market stability. The preferential allotment to non-promoters may slightly dilute promoter holding but strengthens the company’s equity base.
Impact Justification
Standard equity listing with lock-in provisions affecting single company